Skip to content

Investigating the effect of chicory on fatty liver

Investigating the effect of chicory root extract on improving the degree of fatty liver in patients with non-alcoholic fatty liver disease: a randomized clinical trial with a double-blind control group

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231025059862N3
Enrollment
220
Registered
2024-07-27
Start date
2024-08-05
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-alcoholic fatty liver disease. Fatty (change of) liver, not elsewhere classified Nonalcoholic fatty liver disease [NAFLD]

Interventions

Intervention 1: Intervention group: In the intervention group, chicory capsule (containing dried powder of chicory root extract), along with the method of use (one 300 mg capsule three times a day, fa

Sponsors

Gorgan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age 18 to 60 years, male or female, liver grade 2 or 2 to 3 or 3 diagnosed by ultrasound (US) or diagnosis of NAFLD by fibroscan

Exclusion criteria

Exclusion criteria: history of allergy to herbal medicines in the composition, Presence of pregnancy and breastfeeding History of liver problems, including liver cirrhosis.Hereditary liver diseases, such as Wilson's, hemochromatosis and tumoral and parasitic liver diseases, obesity (BMI>35), diabetes participating in another clinical study of fatty liver in 2 months before entering the present study

Design outcomes

Primary

MeasureTime frame
The main outcome is the improvement of the degree of fatty liver during 8 weeks of study. Timepoint: Measurement of fatty liver degree before the intervention, and 8 weeks after the intervention. Method of measurement: sonography.

Secondary

MeasureTime frame
Decrease in the level of aminotransferases. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Laboratory test.;Decrease in the level of fat profile. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Laboratory test.;Decrease in the level of fasting sugar,. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Laboratory test.;Decrease in the level of ferritin. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Laboratory test.;Decrease in the level of total bilirubin. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Laboratory test.;Decrease in the BMI( Body Mass Index). Timepoint: Before the intervention and 8 & 12 weeks after the intervention. Method of measurement: Anthropometric measures.;Decrease in the WHR (Waist to hip). Timepoint: Before the intervention and 8 & 12 weeks after the intervention. Method of measurement: Anthropometric measures.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Zarvandi

Gorgan University of Medical Sciences

dr.zarvandi@goums.ac.ir+98 17 3224 5892

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026